Levetiracetam: A Potent Sword against Microglia Polarization in Gliomas.
Xiaoteng CuiQixue WangXiaomin LiuChun-Sheng KangPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Crosstalk between tumor cells and peritumoral cells contributes to immunosuppressive microenvironment formation in glioblastomas (GBM). A recent study revealed that glioma stem cells activated neuronal activity to promote microglial M2 polarization, leading to GBM progression, which could be pharmacologically blocked by levetiracetam, providing a practical strategy for GBM immunotherapy. See related article by Guo et al., p. 1160.